Navigation Links
The American Society of Hematology Announces New Honorific Award
Date:7/16/2009

WASHINGTON, July 16 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH) announces the debut of the Ernest Beutler Lecture and Prize, to be awarded at ASH's annual meeting in December. The inaugural recipients are Thomas Maniatis, PhD, of Harvard University, and Yuet Wai Kan, MD, of the University of California - San Francisco.

Established in December 2008, this award, named for the late Dr. Ernest Beutler, past president of ASH and physician-scientist for over 50 years, is a two-part lectureship intended to recognize major translational advances related to a single topic. This award honors two individuals, one who has enabled advances in basic science and another individual for achievements in clinical science or translational research. Both of this year's recipients have made seminal contributions to our understanding of the biology and diagnosis of thalassemia, with specific attention paid to the impact of molecular genetic studies of globin genes on the diagnosis and treatment of the disease.

Dr. Kan, past ASH President and prior recipient of the Dameshek Prize and Stratton Medal for his pioneering work involving the use of fetal DNA to diagnose sickle cell anemia and thalassemia, will discuss the development of prenatal and DNA diagnosis for thalassemia, reviewing current and experimental treatments, and the impact of stem cell technology on future therapy.

Dr. Maniatis, of Harvard University, will discuss the development of prenatal and DNA diagnosis for thalassemia, reviewing current and experimental treatments and the impact of stem cell technology on future therapy.

The Ernest Beutler Lecture will take place on Monday, December 7(th) from 12:30 to 1:30 p.m. in New Orleans, LA. For more information, please visit the 51st ASH Annual Meeting Web site.


'/>"/>
SOURCE American Society of Hematology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Michigan Chamber of Commerce Joins Americans Against Food Taxes; Calls Health Care Reform Effort a Job Killer
2. Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz
3. United American Nurses Hails House Health Care Reform Bill
4. Snoring Isn't Sexy, LLC Announces Professional Relationship with the American Sleep Apnea Association
5. American Hygiene Habits Getting Worse: International Study Reveals More Illness-Causing Germs Than Ever in American Kitchens
6. American Imaging Management Debuts Patient Safety Podcasts
7. Study finds survival rates from gastrointestinal tumors improving among African-Americans
8. National Council on Skin Cancer Prevention Encourages Americans to Obtain Vitamin D Through Diet and Supplements
9. American Academy of Dermatology Issues Updated Position Statement on Vitamin D
10. Why African-Americans are at greater risk of hypertension and kidney disease
11. American Red Cross President to Address National Press Club Luncheon

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 3D animation detailing plastic s... Elements website. Surgical candidates can view pr...ctly from the page. , (PR...ine compression garments retailer, has always been...ery patients after their procedures, providing lip...
(Date:12/2/2009)... myEMRchoice.com Enables Personal... Fort Washington, PA (PRWEB) Dec...o give consumers is to read their own medical reco...), keeping control of personal medical records is ...on, PA based healthcare technology company has add...
(Date:12/2/2009)... Award-winning author James A. Fe...th book, Short White Coat: Lessons from Patients o...ough the third year of medical school--the gruelin...ELPHIA, PA (PRWEB) December 2, 2009 -- Most peopl...selves dressed in a tiny hospital gown or staring ...
(Date:12/2/2009)... Leading medical device software ... has received ISO 13485 certification. A relativel...ng firms have actually achieved ISO 13485 certific...ertification and adhere to other ISO standards as ...evice software engineering consulting firm to achi...
(Date:12/2/2009)..., SAN DIEGO, Dec. 2 G...t at the 21st Annual Piper Jaffray Health Care Con...ntation is scheduled to be webcast live and may be...of Gen-Probe,s website at www.gen-probe.com . The...he event. ,, About Gen-Probe ,, Gen-Probe...
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2
...ments for what doctors say is a life-threatening m...hDay News) -- Sen. Edward M. Kennedy enjoyed "a re...of Duke University Medical Center on Tuesday, one ...y was "recuperating well from yesterday,s procedur...
... to be more clear in explaining realities , ...ons not easily understood, many patients with the ...onger than their doctors tell them they will, new ...lity to pump blood -- that the condition would sho...
...nown origin, rheumatoid arthritis (RA) affects abo... destruction, RA often leads to disability and dim...arly death from cancer. Various studies have link...modifying antirheumatic drug (DMARD) commonly pres...
... Underwriters- -Offers Specialized Coverage fo..., June 3 The Hanover,Insurance Group, Inc. (NYSE:...ualty company, today announced it has extended the...ia. The program,offers specialized protection to m...
...ployee,Benefit Research Institute (EBRI) today pub...of the amount of money individuals and couples wil...tirement. The new estimates,attempt to provide mor...f medical care coverage available when they,reach ...
... pancreatic and spinal cancer, SHERWOOD, Ore., Ju...a quiet life at Avamere at,Sherwood in Oregon. The...ngs and frequent visits from his daughter Yolanda ...g cruises for,celebrities. In 1977, he finished Ey...
Other Medicine News:Health News:Sen. Kennedy Up and Walking After Brain Tumor Surgery 2Health News:Sen. Kennedy Up and Walking After Brain Tumor Surgery 3Health News:Sen. Kennedy Up and Walking After Brain Tumor Surgery 4Health News:Heart Failure Patients Overestimate Their Life Expectancy 2Health News:Heart Failure Patients Overestimate Their Life Expectancy 3Health News:Increased incidence of melanoma found in rheumatoid arthritis patients treated with methotrexate 2Health News:Increased incidence of melanoma found in rheumatoid arthritis patients treated with methotrexate 3Health News:The Hanover Extends Schools Program, Making the Grade in GA, KS, MD, and VA 2Health News:The Hanover Extends Schools Program, Making the Grade in GA, KS, MD, and VA 3Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 2Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 3Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 4Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 5Health News:Sherwood, Oregon Sailor, 78, Goes on Final Voyage 2
(Date:12/1/2009)...., Dec. 1 CeloNova BioSciences, In... medical devices and of specialty implants, today ..., founder and medical director of Baptist Cardiac ...iscuss the CATANIA(TM) Stent System with NanoThin ...lar Interventions Conference to be held at the Hot...
(Date:12/1/2009)... and TOKYO, Dec. 1 Galenea Corp. a... the further extension of their research and devel...tension increases the collaboration term to seven ...proximately $90 million. The companies have been ...of discovering and developing first-in-class thera...
(Date:12/1/2009)...., Dec. 1 SCOLR Pharma, ... 20, 2009 it licensed to Chrono Nutraceuticals LLC...l four extended release dietary supplements using ...rm. In addition, SCOLR granted Chrono rights to m...ited States on a nonexclusive basis. Chrono paid ...
Breaking Medicine Technology:Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3American Nurses Association Joins the National Healthcare Career Network 54285 1American Nurses Association Joins the National Healthcare Career Network 54285 2American Nurses Association Joins the National Healthcare Career Network 54285 3Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 1Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 2Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 3The tourist trap 9540 1
...ial New Front-Line Treatment ...Genzyme Corp.,(Nasdaq: GENZ ) reported preliminar...2 study examining the safety and effectiveness of ...ously untreated, older adult,patients with acute m...fit,from conventional "7+3" anthracycline plus cyt...
...CALS, INC. (Nasdaq: VION ) today announced that i... lead anticancer agent Cloretazine(R),(VNP40101M) ...yelogenous,leukemia (AML) had been presented at th...linical Oncology (ASCO(R)) in Chicago, Illinois., ...atients. The median,age of these patients was 73 y...
Other Medicine Technology:Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 8Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 2Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 3Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 4
...t-Cath, Maximum, Maximum Xtra™, and Maximum ...of standard and specialty hemostasis introducers i...mostasis introducers for use in interventional car... angiography, angioplasty, stenting, atherectomy, ...
Lumenis 950 Slit Lamp
Selecta Duo Photocoagulator Combination Laser
Apeel™ CS Catheter Delivery System
Medicine Products: